Dr. Rozy Kamal

Associate Professor

Department of Nuclear Medicine

Qualification: MSc , PhD

CURRENT ACADEMIC ROLE & RESPONSIBILITIES

    Rozy Kamal is an Assistant Professor, Senior Scale in the Department of Nuclear Medicine at MCHP, 亚洲通_亚洲通官网.

    She is:

    • PhD Guide
    • Radiation Safety Officer, Nuclear Medicine Radiation 亚洲通_亚洲通官网 Laboratory?
    • Teaching- Bachelor of Science and Master of Science students of Nuclear Medicine
    • Class Coordinator-BSc. 3rd Semester

SUBJECTS CURRENTLY TEACHING

Subject Semester / Year
Clinical Nuclear Medicine MSc 2nd Semester & BSc 4th, 5th, 6th, 7th and 8th Semester
Radiobiology BSc 3rd Semester
Radiopharmacy MSc 1st Semester and BSc 4th Semester

ACADEMIC QUALIFICATIONS

Degree Specialisation Institute Year of passing
Ph.D. Radiopharmaceuticals and Molecular imaging Panjab University 2015
Master of Science Nuclear Medicine Panjab University 2010
Bachelor of Science Biophysics (Honours School) Panjab University 2008

Experience

Institution / Organisation Designation Role Tenure
亚洲通_亚洲通官网 College of Health Professions, 亚洲通_亚洲通官网 Academy of Higher education Assistant Professor, Senior Scale Teaching and 亚洲通_亚洲通官网 2020 till date
亚洲通_亚洲通官网 College of Health Professions, 亚洲通_亚洲通官网 Academy of Higher education Assistant Professor Teaching and 亚洲通_亚洲通官网 August 21, 2017 to 2020
Centre for Nuclear Medicine, Panjab University 亚洲通_亚洲通官网 Associate 亚洲通_亚洲通官网 June 08, 2015 to March 24, 2017

Synthesizing nanoparticles for hyperthermia induced radiation dose enhancement in cancer therapeutics

Dr. Rozy Kamal Prof. Srinivas Mutalik

Development of multifunctional nanosystems for theranostic application in oncology

Faculty Seed Grant, 亚洲通_亚洲通官网 Academy of Higher Education - Principal Investigator Dr. TMA Pai Intramural Fund, 亚洲通_亚洲通官网 Academy of Higher Education, Principal Investigator

Synthesis and assessment of functionalized gold Iron hybrid nanoparticles for receptor based tumor theranostics in Triple Negative Breast Cancer Brain Metastasis model

Dr.RozyKamal

Molecular characterization and receptor based targeted nanotheranostics of TNBC brain metstatis in mice model

AREAS OF INTEREST, EXPERTISE AND RESEARCH

Area of Interest

Molecular theranostics

Area of Expertise

Radiochemistry and preclinical assessment of radiopharmaceuticals, nanotechnology based targeted radiopharmaceutical delivery, animal and cell culture model studies in cancer prevention and treatment, therapeutic cell tracking techniques for neurological disorders and cancer immunotherapy

Area of 亚洲通_亚洲通官网

Molecular biology investigations leading to theranostic strategies for breast cancer, brain metastasis, neurological disorders, cell based regenerative and immunotherapies, using disease models (cell culture and small animal)

Professional Affiliations & Contributions

Professional Affiliations: ????????????????????????????????????????????????????????????????????????

  • Society of Nuclear Medicine, India (SNMI)
  • Nuclear Medicine Physicist Association of India (NMPAI)
  • Indian Biophysical Society (IBS)

Dose optimization of lithium to increase the uptake and retention of I-131 in rat thyroid

2019-01-02 Sanny Bhushan Kumar Anna Khan Dr. Vijayta D Chadha

Radiat Environ Biophys. DOI: 10.1007/s00411-019-00783-4.

Role of radiation as effective intervention in aβ induced oxidative stress in animal model of Alzheimer’s disease

2019-01-01 Anna Khan Prof. DK Dhawan Dr. Vijayta D Chadha

Asian J Pharm Clin Res 12(1): 227-31

Physiological uptake and retention of radiolabeled resveratrol loaded gold nanoparticles (99mTc-Res-AuNP) in colon cancer tissue.

2018-01-01 Dr. Vijayta D Chadha Prof. DK Dhawan

Nanomedicine: Nanotechnology, Biology and Medicine, 14 (3): 1059-1071.

Chemoprevention by probiotics during 1,2-Dimethylhydrazine induced colon carcinogenesis in rats. Digestive diseases and sciences

2018-01-01 Dr. Sohini Walia Prof. DK Dhawan Prof. SS Kanwar

Digestive diseases and sciences 63(4):900-909 DOI: 10.1007/s10620-018-4249-z

Evaluation of 99mTc-resveratrol as a colon cancer targeting probe. European Journal of Cancer Care

2017-01-01 Prof. DK Dhawan Dr. Vijayta D Chadha

European Journal of Cancer Care. 26 (5) e12504 DOI: 10.1111/ecc.12504

Cyclooxygenase as a Target in Chemoprevention by Probiotics During 1, 2-Dimethylhydrazine Induced Colon Carcinogenesis in Rats

2015-01-01 Dr. Sohini Walia Prof. SS Kanwar Prof. DK Dhawan

Nutrition and Cancer 67(4):603-11 DOI: 10.1080/01635581.2015.1011788

Radiolabeling of Cisplatin and its Bio-distribution in an experimental model of lung carcinogenesis

2014-01-01 Piyali Chatterji Dr. Vijayta D Chadha

Journal of Environmental Pathology Toxicology and Oncology 33(1):11-17 DOI:10.1615/JEnvironPatholToxicolOncol.2014008013

Moderate zinc supplementation during prolonged steroid therapy exacerbates bone loss in rats

2014-01-01 Prof. SC Bansal Prof. N Khandelwal Prof. DV Rai Prof. DK Dhawan.

Biological Trace Element 亚洲通_亚洲通官网 160:383–391 DOI: 10.1007/s12011-014-0063-z

Design and physicochemical characterization of iodine (I-131) labeled polyethyleinimine stabilized magnetic gold nanoparticles

Maya Shetty Prof. Rajesh Kumar

Guide